首页|期刊导航|Oncology Research|Isoliquiritigenin Suppresses Oral Squamous Cell Carcinoma Progression by Targeting FABP5-Mediated Lipid Metabolism:Association with the circPOLB/miR-548ae-3p/C-MYC Axis

Isoliquiritigenin Suppresses Oral Squamous Cell Carcinoma Progression by Targeting FABP5-Mediated Lipid Metabolism:Association with the circPOLB/miR-548ae-3p/C-MYC Axis

Liang Li Hong Deng Zhiyong Li Yu Li Lingrui Liu Lan Xie Yue Chen

Oncology Research2026，Vol.34Issue(8)：P.590-604,15.

Oncology Research2026，Vol.34Issue(8)：P.590-604,15.DOI:10.32604/or.2026.081109

Isoliquiritigenin Suppresses Oral Squamous Cell Carcinoma Progression by Targeting FABP5-Mediated Lipid Metabolism:Association with the circPOLB/miR-548ae-3p/C-MYC Axis

Liang Li ¹Hong Deng ²Zhiyong Li ²Yu Li ²Lingrui Liu ²Lan Xie ²Yue Chen³

作者信息

1. Department of Stomatology,the First Affiliated Hospital of Guangdong Pharmaceutical University,Guangzhou,China
2. State Key Laboratory of Oncology in South China,Guangdong Provincial Clinical Research Center for Cancer,Sun Yat-Sen University Cancer Center,Guangzhou,China
3. Department of Radiation Oncology,Nanfang Hospital,Southern Medical University,Guangzhou,China
折叠

摘要

关键词

Oral squamous cell carcinoma/miR-548ae-3p/c-MYC/circPOLB/FABP5

分类

医药卫生

引用本文复制引用

Liang Li,Hong Deng,Zhiyong Li,Yu Li,Lingrui Liu,Lan Xie,Yue Chen..Isoliquiritigenin Suppresses Oral Squamous Cell Carcinoma Progression by Targeting FABP5-Mediated Lipid Metabolism:Association with the circPOLB/miR-548ae-3p/C-MYC Axis[J].Oncology Research,2026,34(8):P.590-604,15.

基金项目

funding from the Guangdong Basic and Applied Basic Research Foundation(2021A1515111001) （2021A1515111001）

the Outstanding Youths Development Scheme of Nanfang Hospital,Southern Medical University(Grant No.2021J004) （Grant No.2021J004）

the Guangzhou Science and Technology Projects Outstanding Doctoral“Sustained Support”Program for 2025 Basic and Applied Basic Research(2025A04J3276). （2025A04J3276）

Oncology Research

ISSN：0965-0407

访问量0

下载量0

段落导航